Stay updated on Neo-Kan: Adagrasib +/- Nivolumab Clinical Trial
Sign up to get notified when there's something new on the Neo-Kan: Adagrasib +/- Nivolumab Clinical Trial page.

Latest updates to the Neo-Kan: Adagrasib +/- Nivolumab Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA new site revision label 'Revision: v3.3.3' was added. The 'HHS Vulnerability Disclosure' link and the previous 'Revision: v3.3.2' label were removed from the footer.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe Record History now includes Revision: v3.3.2 and removes Revision: v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision history shows minor version updates (added v3.3.1 and removed v3.2.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check49 days agoChange DetectedRemoved the site-wide notice about government funding and NIH operating status from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check63 days agoChange DetectedNew version entry (2025-09-09) was added to the Record History, documenting updates to recruitment status, study status, and study design.SummaryDifference0.1%

- Check92 days agoChange DetectedAdded a prominent operating-status notice and a new version tag (v3.2.0), replacing the previous version (v3.1.0).SummaryDifference12%

Stay in the know with updates to Neo-Kan: Adagrasib +/- Nivolumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neo-Kan: Adagrasib +/- Nivolumab Clinical Trial page.